Fund Holdings — Birchview Capital, LP

Total Portfolio Value:
$115.17M
Total Bought:
$9.66M
Total Sold:
$10.82M
Net Transaction:
-$1.16M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Bristol-Myers Squibb Company(BMY)685,182685,192+10$38.75M$41.79M36.29%+$3.04M
Corcept Therapeutics Incorporated(CORT)74,00066,000-8,000$3.73M$7.54M6.55%+$3.81M
Acadia Pharmaceuticals Inc338,400263,400-75,000$6.21M$4.38M3.80%-$1.83M
Prothena Corp PlcSHS
SHS
304,574332,974+28,400$4.22M$4.12M3.58%-$97.8K
Biodesix, Inc.(BDSX)5,736,1135,736,1130$8.78M$3.59M3.11%-$5.19M
Neurocrine Biosciences, Inc.(NBIX)30,24030,2400$4.13M$3.34M2.90%-$783.2K
Elutia Inc.(ELUT)1,225,4891,187,735-37,754$4.58M$3.00M2.61%-$1.58M
Axogen, Inc.(AXGN)197,000161,000-36,000$3.25M$2.98M2.59%-$268.1K
Phreesia, Inc.(PHR)114,700114,7000$2.89M$2.93M2.55%+$45.9K
Travere Therapeutics, Inc.(TVTX)148,000138,000-10,000$2.58M$2.47M2.15%-$105.2K
Quidelortho Corp67,61967,6190$3.01M$2.36M2.05%-$647.8K
Protagonist Therapeutics Inc48,00048,002+2$1.85M$2.32M2.02%+$468.6K
United Therapeutics Corporation(UTHR)10,0007,500-2,500$3.53M$2.31M2.01%-$1.22M
DocGo Inc.(DCGO)764,062864,062+100,000$3.24M$2.28M1.98%-$958.5K
Ovintiv Inc.(OVV)52,20052,2000$2.11M$2.23M1.94%+$120.1K
Harrow, Inc.(HROW)72,91072,9100$2.45M$1.94M1.68%-$506.7K
Masimo Corp15,28011,280-4,000$2.53M$1.88M1.63%-$646.5K
EQT Corporation(EQT)34,61934,6190$1.60M$1.85M1.61%+$253.4K
Castle Biosciences, Inc.(CSTL)78,00088,404+10,404$2.08M$1.77M1.54%-$308.9K
Alkermes plcSHS(ALKS)50,00050,0000$1.44M$1.65M1.43%+$213.0K
Stoke Therapeutics, Inc.(STOK)210,000210,005+5$2.32M$1.40M1.21%-$919.8K
Treace Medical Concepts, Inc.(TMCI)161,350164,947+3,597$1.20M$1.38M1.20%+$183.5K
Foghorn Therapeutics Inc.(FHTX)310,930310,9300$1.47M$1.13M0.99%-$332.7K
uniQure N.V.SHS(QURE)20,00088,697+68,697$353.2K$940.2K0.82%+$587.0K
Kalvista Pharmaceuticals Inc67,00067,002+2$567.5K$773.2K0.67%+$205.7K
Xenon Pharmaceuticals Inc.(XENE)10,00021,000+11,000$392.0K$704.5K0.61%+$312.6K
Axsome Therapeutics, Inc.(AXSM)4,0006,000+2,000$338.4K$699.8K0.61%+$361.3K
Kiniksa Pharmaceuticals Ltd30,00030,006+6$593.4K$666.4K0.58%+$73.0K
Halozyme Therapeutics, Inc.(HALO)10,00010,0000$478.1K$638.1K0.55%+$160.0K
Ultragenyx Pharmaceutical Inc.(RARE)16,00016,0000$673.1K$579.4K0.50%-$93.8K
NovoCure Limited(NVCR)31,00031,0000$923.8K$552.4K0.48%-$371.4K
Scholar Rock Holding Corporation(SRRK)8,00016,000+8,000$345.8K$514.4K0.45%+$168.6K
OrthoPediatrics Corp.(KIDS)020,000+20,000$0$492.6K0.43%+$492.6K
Solid Biosciences Inc0128,768+128,768$0$476.4K0.41%+$476.4K
Inhibrx Biosciences, Inc.(INBX)32,11032,1100$494.5K$449.2K0.39%-$45.3K
10x Genomics, Inc.CL A(TXG)50,00050,0000$718.0K$436.5K0.38%-$281.5K
Cytokinetics, Incorporated(CYTK)10,00010,0000$470.4K$401.9K0.35%-$68.5K
Springworks Therapeutics Inc10,0008,280-1,720$361.3K$365.4K0.32%+$4.1K
Pulmonx Corporation(LUNG)51,00051,0000$346.3K$343.2K0.30%-$3.1K
Candel Therapeutics, Inc.(CADL)60,00060,0000$520.8K$339.0K0.29%-$181.8K
Alphatec Holdings, Inc.(ATEC)58,00033,000-25,000$532.4K$334.6K0.29%-$197.8K
Wave Life Sciences, Inc.SHS(WVE)40,00040,300+300$494.8K$325.6K0.28%-$169.2K
MoonLake ImmunotherapeuticsCL A(MLTX)4,0008,000+4,000$216.6K$312.6K0.27%+$96.0K
Apellis Pharmaceuticals Inc
COM
14,00014,0000$446.7K$306.2K0.27%-$140.6K
BioCryst Pharmaceuticals, Inc.(BCRX)40,00040,0000$300.8K$300.0K0.26%-$800
Apogee Therapeutics Inc08,000+8,000$0$298.9K0.26%+$298.9K
Xencor, Inc.(XNCR)26,00026,0000$597.5K$276.6K0.24%-$320.8K
Outset Medical, Inc.(OM)368,76624,584-344,182$409.3K$271.9K0.24%-$137.4K
Blueprint Medicines Corp2,7002,7000$235.5K$239.0K0.21%+$3.5K
Amicus Therapeutics Inc
COM
28,00028,0000$263.8K$228.5K0.20%-$35.3K
Accelerate Diagnostics Inc325,239325,2390$390.3K$228.0K0.20%-$162.3K
Arvinas, Inc.(ARVN)15,00030,000+15,000$287.6K$210.6K0.18%-$77.0K
NeuroPace, Inc.(NPCE)10,00016,442+6,442$111.9K$202.1K0.18%+$90.2K
TELA Bio, Inc.(TELA)125,000155,000+30,000$377.5K$189.1K0.16%-$188.4K
Keros Therapeutics, Inc.(KROS)15,00015,0000$237.4K$152.8K0.13%-$84.6K
Gossamer Bio, Inc.(GOSS)138,176138,1760$125.0K$152.0K0.13%+$27.0K
Cullinan Therapeutics, Inc.(CGEM)20,00020,0000$243.6K$151.4K0.13%-$92.2K
Liquidia Corporation(LQDA)10,00010,013+13$117.6K$147.7K0.13%+$30.1K
Direxion Daily Pharmaceutical & Medical Bull 3x ShDLY TECH BULL 3X
DA TE BU 3X ETF
18,00020,000+2,000$127.8K$144.4K0.13%+$16.6K
Atara Biotherapeutics Inc22,00022,0000$292.8K$130.7K0.11%-$162.1K
Zenas BioPharma, Inc.(ZBIO)16,50016,5000$135.1K$130.3K0.11%-$4.8K
Karyopharm Therapeutics Inc.(KPTI)419,83227,985-391,847$283.9K$104.7K0.09%-$179.3K
2seventy Bio Inc15,83315,500-333$46.5K$76.6K0.07%+$30.0K
Alumis Inc10,00010,0000$78.6K$61.4K0.05%-$17.2K
InflaRx N.V.(IFRX)50,00050,0000$123.5K$51.0K0.04%-$72.5K
Compass Therapeutics, Inc.(CMPX)024,000+24,000$0$45.6K0.04%+$45.6K
Ventyx Biosciences Inc28,80028,8000$63.1K$33.1K0.03%-$30.0K
Zentalis Pharmaceuticals, Inc.(ZNTL)17,00017,0000$51.5K$27.0K0.02%-$24.5K
Biohaven Pharmaceutical Holding Co Ltd7,3650-7,365$275.1K$0—-$275.1K
CERo Therapeutics Holdings, Inc.CL A(CERO)12,9720-12,972$778$0—-$778
Coherus Oncology, Inc.(CHRS)82,0000-82,000$113.2K$0—-$113.2K
Sarepta Therapeutics, Inc.(SRPT)3,5000-3,500$425.6K$0—-$425.6K
Page 1 of 1